Elanco Animal Ownership
| ELAN Stock | USD 10.53 0.05 0.47% |
Shares in Circulation | First Issued 2017-09-30 | Previous Quarter 498 M | Current Value 497 M | Avarage Shares Outstanding 435.3 M | Quarterly Volatility 72.8 M |
Elanco |
Elanco Stock Ownership Analysis
About 99.0% of the company shares are held by institutions such as insurance companies. The company has price-to-book (P/B) ratio of 0.85. Some equities with similar Price to Book (P/B) outperform the market in the long run. Elanco Animal Health has Price/Earnings To Growth (PEG) ratio of 1.19. The entity had not issued any dividends in recent years. Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. Elanco Animal Health Incorporated was founded in 1954 and is headquartered in Greenfield, Indiana. Elanco Animal operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on New York Stock Exchange. It employs 9000 people. To learn more about Elanco Animal Health call Jeffrey Simmons at 877 352 6261 or check out https://www.elanco.com.Besides selling stocks to institutional investors, Elanco Animal also allocates a substantial amount of its earnings to a pull of share-based compensation to be paid out to its employees, managers, executives, and members of the board of directors. Share-Based compensation (also sometimes called Stock-Based Compensation) is a way of paying different Elanco Animal's stakeholders with equity in the business. It is typically used as a motivation factor for employees to contribute beyond their regular compensation (salary and bonus). It is also used as a tool to align Elanco Animal's strategic interests with those of the company's shareholders. Shares issued to employees are usually subject to a vesting period before they are earned and sold.
Elanco Animal Quarterly Liabilities And Stockholders Equity |
|
Elanco Animal Insider Trades History
Less than 1% of Elanco Animal Health are currently held by insiders. Unlike Elanco Animal's institutional investors, corporate insiders most likely have a limit on the maximum percentage of share ownership. This is done to align insiders' influence against Elanco Animal's private investors even though both sides will benefit from rising prices or experience loss when the share price declines. The good rule to have in mind is that the maximum share ownership percentage of the corporate insiders should not surpass 25%. View all of Elanco Animal's insider trades
Elanco Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Elanco Animal is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Elanco Animal Health backward and forwards among themselves. Elanco Animal's institutional investor refers to the entity that pools money to purchase Elanco Animal's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | State Street Corp | 2024-12-31 | 10.4 M | Geode Capital Management, Llc | 2024-12-31 | 8.2 M | Jpmorgan Chase & Co | 2024-12-31 | 7.5 M | Manufacturers Life Insurance Co | 2024-12-31 | 6.9 M | Brandes Investment Partners & Co | 2024-12-31 | 5.7 M | Charles Schwab Investment Management Inc | 2024-12-31 | 4.7 M | Prudential Financial Inc | 2024-12-31 | 4.2 M | Ubs Group Ag | 2024-12-31 | 4.2 M | Canada Pension Plan Investment Board | 2024-12-31 | 4 M | Dodge & Cox | 2024-12-31 | 83.2 M | Primecap Management Company | 2024-12-31 | 51.2 M |
Elanco Animal Health Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Elanco Animal insiders, such as employees or executives, is commonly permitted as long as it does not rely on Elanco Animal's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Elanco Animal insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Elanco Animal's latest congressional trading
Congressional trading in companies like Elanco Animal Health, is subject to rigorous scrutiny to prevent conflicts of interest and insider trading. This is governed by multiple SEC regulations which were established to foster transparency and deter members of Congress from leveraging non-public information for personal gain. This oversight helps maintain public trust and ensures that investments in Elanco Animal by those in governmental positions are based on the same information available to the general public.
| 2024-10-08 | Representative Ro Khanna | Acquired Under $15K | Verify | ||
| 2023-07-26 | Senator Dan Sullivan | Acquired Under $15K | Verify | ||
| 2022-12-21 | Senator Dan Sullivan | Acquired Under $15K | Verify | ||
| 2022-06-30 | Representative Alan S Lowenthal | Acquired Under $15K | Verify |
Elanco Animal Outstanding Bonds
Elanco Animal issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Elanco Animal Health uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Elanco bonds can be classified according to their maturity, which is the date when Elanco Animal Health has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| Elanco Animal Health Corp BondUS28414HAG83 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View | |
| US28415LAA17 Corp BondUS28415LAA17 | View | |
| AerCap Global Aviation Corp BondUS00773HAA59 | View |
Elanco Animal Corporate Filings
8K | 17th of March 2025 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
F4 | 11th of March 2025 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
| 7th of March 2025 Other Reports | ViewVerify | |
| 12th of February 2025 Other Reports | ViewVerify |
Pair Trading with Elanco Animal
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Elanco Animal position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Elanco Animal will appreciate offsetting losses from the drop in the long position's value.Moving together with Elanco Stock
| 0.7 | CDIOW | Cardio Diagnostics | PairCorr |
| 0.64 | VINC | Vincerx Pharma Earnings Call This Week | PairCorr |
| 0.66 | ELEV | Elevation Oncology | PairCorr |
| 0.62 | ELVN | Enliven Therapeutics | PairCorr |
Moving against Elanco Stock
| 0.87 | OCX | OncoCyte Corp | PairCorr |
| 0.84 | GILD | Gilead Sciences | PairCorr |
| 0.81 | AZN | AstraZeneca PLC ADR | PairCorr |
| 0.78 | GOSS | Gossamer Bio | PairCorr |
| 0.76 | SNY | Sanofi ADR | PairCorr |
The ability to find closely correlated positions to Elanco Animal could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Elanco Animal when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Elanco Animal - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Elanco Animal Health to buy it.
The correlation of Elanco Animal is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Elanco Animal moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Elanco Animal Health moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Elanco Animal can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Elanco Animal Health. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Elanco Animal. If investors know Elanco will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Elanco Animal listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.71) | Earnings Share 0.68 | Revenue Per Share | Quarterly Revenue Growth (0.01) | Return On Assets |
The market value of Elanco Animal Health is measured differently than its book value, which is the value of Elanco that is recorded on the company's balance sheet. Investors also form their own opinion of Elanco Animal's value that differs from its market value or its book value, called intrinsic value, which is Elanco Animal's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Elanco Animal's market value can be influenced by many factors that don't directly affect Elanco Animal's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Elanco Animal's value and its price as these two are different measures arrived at by different means. Investors typically determine if Elanco Animal is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Elanco Animal's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.